Two Cases of Lung Stage ⅢSquamous Cell Carcinoma Treated with Carboplatin (CBDCA) plus Nab-Paclitaxel (Nab-PTX)
Yoshino, Y.; Miyagi, J.; Toume, R.; Naha, Y.; Uchihara, T.; Akamine, M.; Nakazato, H.; Kawakami, M.; Tomori, T.; Nagayoshi, S.; Nagamine, S.; Tomiyama, T.; Ohmine, Y.; Sasaki, H.; Ishikawa, M.; Maeshiro, K.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(7): 1171-1173
2019
ISSN/ISBN: 0385-0684 PMID: 31296824 Document Number: 698392
Case 1: 83 years old man. For left upper lobe lungs squamous cell carcinoma infiltrating left main pulmonary artery. After 2 courses went of carboplatin(CBDCA)(AUC: 6)+weekly nab-paclitaxel(nab-PTX)(AUC: 6)+, left upper lobectomy and ND2 lymph nodes dissection. Tumor disappeared in pathology and diagnosed of Ef. 3. Case 2: 81 years old man. Right upper lobe lungs squamous cell carcinoma in #4R lymph node metastasis with the superior vena cava invasion. After 2 courses went of CBDCA(AUC: 6)+weekly nab-PTX(100mg/m2), left upper lobectomy and ND2 lymph nodes dissection. Tumor disappeared in pathology and diagnosed of Ef. 3. Nab-PTX may be considered a preoperative chemotherapeutic agent of choice for squamous cell carcinoma.